Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Total Debt (2023 - 2025)

Baird Medical Investment Holdings' quarterly Total Debt came in at $8.7 million in Q4 2025, up 102.38% year-on-year from $4.3 million in Q4 2024, and up 33.51% quarter-over-quarter from $6.5 million in Q2 2025.

Baird Medical Investment Holdings has reported Total Debt for 3 years, with the latest figure at $8.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 102.38% year-over-year to $8.7 million; the trailing twelve-month figure through Dec 2025 stood at $8.7 million (up 102.38% YoY), and the FY2025 full-year result was $8.7 million, up 102.38% from the prior year.
  • Total Debt for Q4 2025 stood at $8.7 million, up from $6.5 million in the prior quarter.
  • The five-year high for Total Debt was $8.7 million in Q4 2025, with the low at -$8433.0 in Q2 2024.
  • Average Total Debt over 3 years is $4.4 million, with a median of $4.3 million recorded in 2024.
  • Year-over-year, Total Debt surged 77.3% in 2024 and soared 77579.62% in 2025.
  • Tracing BDMDW's Total Debt over 3 years: stood at $2.4 million in 2023, then surged by 77.3% to $4.3 million in 2024, then soared by 102.38% to $8.7 million in 2025.
  • The last three Total Debt figures came in at $8.7 million (Q4 2025), $6.5 million (Q2 2025), and $4.3 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 34.05 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.72 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 28.07 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.93 Bn
10 Baird Medical Investment Holdings - - - 8.72 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 8.72 Mn
Jun 30, 2025 6.53 Mn
Dec 31, 2024 4.31 Mn
Jun 30, 2024 -8,433.00
Dec 31, 2023 2.43 Mn